BMO Capital Reiterates Outperform Rating on MyoKardia (MYOK) Ahead of ACC Presentation
Tweet Send to a Friend
BMO Capital analyst George Farmer reiterated an Outperform rating and $90.00 price target on MyoKardia (NASDAQ: MYOK) ahead of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
